EUPRAXIA PHARMACEUTICALS INC. (EPRX) Operating cash flow 2022–2025
EUPRAXIA PHARMACEUTICALS INC. (EPRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.6MFY2025 · since FY2022: -$14.4M → -$28.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.6M | +4.8% |
| FY2024 | -$30.0M | -44.6% |
| FY2023 | -$20.7M | -44.1% |
| FY2022 | -$14.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More EPRX financial trends
EPRX RevenueEPRX Net incomeEPRX Net marginEPRX Gross profitEPRX Gross marginEPRX Operating incomeEPRX Operating marginEPRX Free cash flowEPRX Capital expendituresEPRX Return on equityEPRX Stock buybacksEPRX Dividends paidEPRX Total assetsEPRX Total liabilitiesEPRX Shareholders’ equityEPRX overview →